European Leukemia Trial Registry
Trial: ALL GMALL 07/2003 mit Rituximab

More Details
Title Therapy optimization with Rituximab in ALL-standard risk (concomitant study to GMALL 07/2003)
Scientific Title Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Short Title ALL GMALL 07/2003 mit Rituximab
Trialgroup GMALL
Type of Trial multicentric
Disease Acute lymphoblastic leukemia(ALL) B-Precursor ALL
Age <= 65 years
Status Closed
Start of Recruitment 01.04.2004
Leader Hoelzer, Prof. Dr. med., Dieter
Contactperson

Study Physician
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Study Centre
Koy-Redemann, Regina
Tel: +49 (0)69 6301-87146
Fax: +49 (0)69 6301-7463
Email: koy-redemann@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 04.07.2006 Anja Hellenbrecht
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org